$MEDP

Medpace Holdings, Inc.

$467.34
-7.73 (-1.63%) Today

About Medpace Holdings, Inc.

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.

CEO
Dr. August James Troendle M.D.
Employees
6,300
Headquarters
Cincinnati, OH
Sector
Healthcare
Industry
Diagnostics & Research
Website
medpace.com

Key stats

Market Cap
$13.35B
P/E Ratio
29.41
Avg Volume (3M)
364.32K
EPS
$15.89
Day's Range
$466.40 – $479.30

Fundamentals as of Jun 15, 2026